Diabetes technology section
SpectRx, Inc. is developing a non-invasive test to screen for diabetes by measuring the intensity of fluorescence and scattering in the lens of the eye. Eye measurements are performed through an undilated pupil with the assistance of a pupil tracking system.
Current insulin pens are more convenient than injections with syringes, but they could do so much more. They could be designed like today's smart insulin pumps, and could even be designed to be far more intelligent so they really improve control.
Blue skying means sitting around with friends and sharing what-if ideas. Maybe it's a way to cure diabetes, or to make scattered blood sugar results mean something, or to prevent or treat retinopathy, or a software program that could help deal with diabetes. Whatever it is, this is the place to share it.
The Dexcom STS and the Paradigm RT continuous monitors are currently available in the U.S. with a prescription. In this study, they are compared head to head while being worn by one person with Type 1 diabetes. Over 33 days, 262 simultaneous readings were compared between a One Touch meter and the two continuous monitors. The meter was used to calibrate both monitors and as the standard against which their accuracy was evaluated.